Gerhard Zugmaier

10PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 29, 2023
Transient and fully reversible changes in laboratory parameters and modifications of the cytokine profile during blinatumomab treatment in children with relapsed or refractory B-cell acute lymphoblastic leukemia.

Franco Locatelli, Ana Markovic, Matthias Klinger

|Jan 04, 2023
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study.

Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis

|Apr 28, 2022
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia.

Franco Locatelli, Cornelia Eckert, Ondrej Hrusak

|Sep 14, 2021
CD19 expression in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia pre- and post-treatment with blinatumomab.

Ester Mejstrikova, Matthias Klinger, Ana Markovic

Pageof 2

Frequent Collaborators

5 joint publications

Franco Locatelli

2 joint publications

Cornelia Eckert

2 joint publications

Carmelo Rizzari

2 joint publications

Bernd Gruhn